Global Digital Therapeutic (DTx) Markets, 2019-2020 & 2021-2027 – Rise in Emphasis on Preventive Healthcare will have a Positive Impact – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Digital Therapeutic (DTx) Market” report has been added to ResearchAndMarkets.com’s offering.

Increase in incidences of preventable chronic diseases considered as key driving factor which is expected to boost the global digital therapeutic (DTx) market growth.

Furthermore, rise in emphasis on preventive healthcare will have the positive impact on market growth. Moreover, increase in number of venture capitalists that are investing in the market will fuel the market growth.

In addition to that, increase in internet usage as well as dependency on smartphones, digital therapeutics (DTx) provide easy tracking and monitoring of patients and their vital stats without invention expected to propel the market growth during this forecast period.

Market Restraints

However, data safety and security is the major restraining factor which expected to hamper the global digital therapeutic (DTx) market growth. Also, lack of awareness and access to digital therapeutics programs in developing countries, and reluctance among patients to adopt digital therapeutics are some challenging factor which are expected to hinder the market growth.

Market Key Players

• Proteus Digital Health
• Omada Health
• Livongo Health
• Noom
• Welldoc
• Ginger
• Propeller Health
• 2Morrow
• Canary Health
• Mango Health Inc

Key Questions Addressed by the Report

• What are the Key Opportunities in Global Digital Therapeutic (DTx) Market?
• What will be the growth rate from 2019 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Global Digital Therapeutic (DTx) Market Outlook

4.1 Overview

4.2 Market Dynamics

4.3 Porters Five Force Model

4.4 Value Chain Analysis

5 Global Digital Therapeutic (DTx) Market, By Application

5.1 Y-o-Y Growth Comparison, By Application

5.2 Global Digital Therapeutic (DTx) Market Share Analysis, By Application

5.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By Application

5.3.1 Diabetes

5.3.2 CVD

5.3.3. Obesity

5.3.4. CNS Diseases

5.3.5. Respiratory Diseases

5.3.6. Smoking Cessation

5.3.7. Others

6 Global Digital Therapeutic (DTx) Market, By End Use

6.1 Y-o-Y Growth Comparison, By End Use

6.2 Global Digital Therapeutic (DTx) Market Share Analysis, By End Use

6.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By End Use

6.3.1 Patients

6.3.2 Providers

6.3.3 Payers

6.3.4 Employers

6.3.5. Others

7 Global Digital Therapeutic (DTx) Market, By Region

7.1 Global Digital Therapeutic (DTx) Market Share Analysis, By Region

7.2 Global Digital Therapeutic (DTx) Market Share Analysis, By Region

7.3 Global Digital Therapeutic (DTx) Market Size and Forecast, By Region

8 North America Digital Therapeutic (DTx) Market Analysis and Forecast (2017 – 2027)

9 Europe Digital Therapeutic (DTx) Market Analysis and Forecast (2017 – 2027)

10 Asia Pacific Digital Therapeutic (DTx) Market Analysis and Forecast (2017 – 2027)

11 Latin America Digital Therapeutic (DTx) Market Analysis and Forecast (2017 – 2027)

12 Middle East Digital Therapeutic (DTx) Market Analysis and Forecast (2017 – 2027)

13 Competitive Analysis

13.1 Competition Dashboard

13.2 Market share Analysis of Top Vendors

13.3 Key Development Strategies

14 Company Profiles

15.1 Overview

15.2 Offerings

15.3 Key Financials

15.4 Business Segment & Geographic Overview

15.5 Key Market Developments

15.6 Key Strategies

For more information about this report visit https://www.researchandmarkets.com/r/wayts

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900